Medical Cannabis Clinician Brief Pack: Top 10 Conditions in Older Adults (Nationwide Edition, PDF)

Your older patients are already asking about medical cannabis. This pack helps you get oriented quickly and honestly before that conversation happens.

Each brief brings together a deliberate mix of sources: - the 2017 National Academies consensus report, with its conclusion quoted word for word - Cochrane systematic reviews where one exists (and a note where none does) - recent PubMed-indexed trials, reviews and studies of older adults - NIH pages from NCCIH, NCI and others - the National Conference of State Legislatures (NCSL) state-law summary, plus each state's official program site - Granny Storm Crow's List (patient-community index, for orientation only)

Every citation was checked against PubMed or the source's own site in October 2026. Nothing is overstated, and nothing tells you what to prescribe.

Inside (15 pages, US Letter PDF, with a clickable contents page and bookmarks): - 10 one-page condition briefs: - Chronic Pain & Arthritis - Neuropathic Pain - Insomnia & Sleep - Appetite & Weight Loss - Anxiety & Depression - Parkinson's Disease - Alzheimer's & Dementia Symptoms - Cancer & Chemotherapy Side Effects - Glaucoma - Migraine & Headache - In each brief: - An at-a-glance strip with four boxes: - the National Academies evidence grade - whether a Cochrane review exists - the number of PubMed records in adults 65+ - the number of states with medical cannabis programs (41 states + DC, per NCSL) - The National Academies (2017) conclusion, quoted word for word - 8–10 verified sources, each tagged by type (NASEM, COCHRANE, PUBMED, NIH, STATE, LIST), with clickable PubMed and DOI links - Four geriatric-considerations questions (falls, cognition, sedative load, renal/hepatic issues, polypharmacy, monitoring) - Drugs.com interaction-checker links to review with a pharmacist - A state-rules note: eligibility, certification and qualifying-condition lists vary by state, with a pointer to your state's official program in Appendix A - Appendix A: a 50-state + DC table of medical-cannabis programs with each state's official site. It reflects the April 2026 federal Schedule III change for state-licensed medical cannabis. Current as of October 2026. - Appendix B: the source mix, how every citation was verified, and the evidence's limits (few trials enroll adults 65+).

Good for: primary care, geriatrics, palliative care, pain, neurology and oncology teams, and pharmacists. It gives you a credible, cited starting point instead of a search-engine rabbit hole.

Nationwide Edition: written for clinicians in any state. Each brief stays state-neutral and points you to your own state's official program in Appendix A, because eligibility, certification steps and qualifying-condition lists differ from state to state.

Education only. These briefs are a research-navigation aid. They are not medical, legal or prescribing advice. They do not diagnose, prescribe, recommend products, set doses or titration, or give drug-interaction verdicts. Cited titles and conclusions are summarized for orientation only. Read the original sources before relying on any of them. Clinical decisions remain with the treating clinician. Confirm all laws and program rules on official state sites. For use with licensed, state-regulated medical cannabis programs only.

Sources include the National Academies of Sciences, Engineering, and Medicine (2017), Cochrane reviews, studies indexed in PubMed, NIH pages (NCCIH, NCI and others), the National Conference of State Legislatures (NCSL), official state program sites, and Granny Storm Crow's List (a patient-community research index, for orientation only). This is an independent guide and is not endorsed by any cited source. Prepared by Annie Romelfanger, author of Medical Cannabis Handbook: A Friendly Guide to Safe, Simple Healing. Last reviewed: October 2026. Corrections: romelfanger@proton.me.